EECP History

EECP history begins in the 1950s at Harvard University.  At t his time in the earliest days of EECP history, the first counterpulsation technology with water hydraulics was invented. Soon thereafter, scientists and engineers in China collaborated with Americans to create what we know today as Enhanced External Counterpulsation or EECP. The term Enhanced External Counterpulsation was coined in the 1990s by Dr. John Hui, a founder of Vasomedical. He and his collaborators went on to describe an improved, proprietary technology for better ECP therapy.

In the annals of EECP, initial technology addressed chronic stable angina pectoris. Several clinical trials were conducted and worldwide, scientists, researchers and academicians have completed studies featuring EECP on a variety of clinical diagnoses.

EECP History

EECP Historical Timeline


Vasomedical begins manufacturing the Luminar

Vasomedical stops production of the TS3 and begins manufacturing the Luminar.


“EECP is a Regenerative Therapy”

“EECP is a Regenerative Therapy,” published in Frontiers in Bioscience magazine, clinical researchers from Texas A&M Health Science Center College of Medicine and Cardiology showed that EECP therapy is likely to regenerate circulatory stem cells of diseased organs in the body.


Sara Soulati opens Global Cardio Care-West Los Angeles.

Sara Soulati opens Global Cardio Care-West Los Angeles.

Sara Soulati opens Global Cardio Care-West Los Angeles.


FDA Cardiology Committee

The FDA cardiology committee met to review external counterpulsation. They decided that EECP/ECP had been proven safe and effective in the treatment of refractory angina with patients in clinical studies to lower the classification from Class III to Class II. This permits EECP/ECP devices to be regulated under the 510(k) regulations.


Sara Soulati applies for a patent

Sara Soulati applies for a patent for the Sara Soulati Health for Life Program


Dr. Hui Aligns with Sara in China

Dr. Hui aligns with Sara in China to disclose Vamed’s new generation MC2, now called the MC3. Cedars-Sinai Medical Center in Los Angeles, the University of Chicago Medical School and the American Heart Association publish the results of Sara’s Health For Life Program combined with EECP using the MC2 device. The results detail her program..Read More

Call Us Today!

Schedule a Complimentary Session of Our EECP Program